11 h. ago Swiggy Upgraded To Buy By Motilal Oswal, Maintains Buy On Eternal; Sees Structural Tailwinds To Drive Growth

Lower GST burden provides a structural tailwind for penetration and unit economics.

Politics

32 h. ago GST 2.0 Reform Boosts Markets, Business Sentiment; Check Key Stock Beneficiaries: Motilal Oswal Report

Maruti, M&M, Ashok Leyland, HUL, Britannia, HDFC Bank, Varun Beverages, Ultratech, JK Cement, Havells, Voltas, Amber, Metro, Trent, Lemon Tree, Swiggy, Zomato among key stock benerficiaries.

Economics

33 h. ago GST Exemption On Retail Insurance Set To Boost Demand; HDFC Life, Niva Bupa Among Motilal Oswal's Top Picks

The change will be effective from September 22, 2025; GST cuts to benefit policyholders, says Motilal Oswal

Politics

58 h. ago 'Buy' ICICI Bank Shares Maintains Motilal Oswal, Sees Upto 20% Potential Upside

The continued improvement in asset mix, limited NIM compression and healthy growth in business banking and select retail segments position ICICI Bank well to deliver robust profitability.

Economics

3 d. ago Phoenix Mills In Focus As Motilal Oswal Upgrades To 'Buy' On Order Pipeline: Check Target Price

Phoenix Mills is on the verge of a new phase of growth as it commissions a series of new retail properties. The new projects are expected to drive growth beyond the fiscal year 2027.

Economics

3 d. ago 'Buy' Mastek Shares Maintains HDFC Securities On Strong Growth Momentum In UK 

HDFC Securities maintains its current estimates and expect Mastek to deliver a 12% revenue and 14% EPS CAGR over FY25-28E.

Politics

3 d. ago Phoenix Mills Gets 'Buy' Upgrade From Motilal Oswal, Sees 35% Potential Upside

Commissioning of new malls to drive growth beyond FY27, says Motilal Oswal hence hikes target price.

Politics

3 d. ago Stock Picks Today: Phoenix Mills, Nestle India, RIL, Bajaj Finance on Brokerages' Radar

Motilal Oswal and Morgan Stanley have raised the target price on Phoenix Mills and RIL, respectively.

Politics

4 d. ago India's strong economic growth fails to impress equity investors

India's strong economic growth fails to impress equity investors  Reuters

Economics

4 d. ago Suzlon Energy Shares Up 2% As Motilal Oswal Initiates Coverage With 'Buy'

Shares of Suzlon Energy last traded 2.02% higher at Rs 57.57 apiece on the BSE. Motilal Oswal is bullish on the stock over order bool volume.

Politics

7 d. ago Amber Enterprises Gets PL Capital's 'Buy' Rating As It Initiates Coverage

PL Capital is positive on Amber Enterprises and initiates coverage with a 'Buy' call citing strong growth outlook and diversification plans.

Politics

7 d. ago ICICI Bank, HDFC Bank, SBI Are Motilal Oswal's Top Pick In Bank Stocks

The potential recovery in earnings in H2 FY26 will mark an end to the multi-year earnings deceleration cycle and help improve sector performance, adds Motilal Oswal.

Politics

7 d. ago Dr. Agarwal's Health Care, Eye Hospital's Merger Synergies To Drive EPS Accretion; Motilal Oswal Maintains Buy

The merger will be subject to requisite approvals from shareholders, stock exchanges, SEBI, and the NCLT.

Science

8 d. ago HUL, Marico, Titan, Page Industries Among Motilal Oswal's Top Picks In Consumer Sector

Consumption trends saw a sequential improvement in Q1, with jewelry and liquor categories sustaining their outperformance, adds Motilal Oswal.

Politics

9 d. ago KEC International Targets 15% Growth In FY26 Driven By Strong Demand In T&D Segment

MD and CEO Vimal Kejriwal acknowledged ongoing execution challenges while projecting a positive outlook for the next few years.

Events

1 week ago Star Health Navigating Growth With Caution, Says Motilal Oswal Maintaining 'Buy'

Motilal Oswal maintains Buy rating on Star Health with a target price of Rs 520.

Politics

1 week ago Motilal Oswal Initiates Coverage On These Three IT Stocks With Buy And Sell Rating

KPIT leads amid software shift, peers face margin pressures, adds Motilal Oswal

Politics

1 week ago Divi's Labs Shares In Focus As Jefferies Upgrades To 'Buy', Eyes 16% Upside On Sustained Growth Momentum

Divi's Laboratories' custom synthesis segment has clocked strong year-on-year growth of 19% in the financial year 2025. Sacubitril Valsartan has led the growth in this segment, Jefferies said.

Politics

2 w. ago Motilal Oswal Recommends 'Buy' On Sunteck Realty With 43% Upside Potential Citing Strong Growth Prospects

Motilal Oswal has issued a "Buy" rating on Sunteck Realty, setting a target price of Rs 561-indicating a potential upside of 43% from its current market price of Rs 393.

Politics

2 w. ago Dixon Technologies Can Rally 33% Says Motilal Oswal Maintaining 'Buy'

Motilal Oswal also incorporate the value of stake in Aditya Infotech, hence reiterates Buy rating on the stock and hikes target price.

Politics